Cited by 121Probiotics and Fermented FoodsInfant Nutrition and HealthInfant Health and Development

Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy

Open access
Allen, Stephen J., Jordan, Susan, Storey, Melanie, Thornton, Catherine A., Gravenor, Michael, Garaiova, Iveta, Plummer, Susan F., Wang, Duolao +1 more·2010·The Journal of Nutrition

Abstract

Lactic acid bacteria and bifidobacteria are increasingly being administered to pregnant women and infants with the intention of improving health. Although these organisms have a long record of safe use, it is important to identify any adverse effects in potentially vulnerable populations. In a randomized, double-blinded, placebo-controlled trial, we evaluated the safety of a bacterial dietary supplement for the prevention of atopy in infants. Two strains of lactobacilli (Lactobacillus salivarius CUL61 and Lactobacillus paracasei CUL08) and bifidobacteria (Bifidobacterium animalis subsp. lactis CUL34 and Bifidobacterium bifidum CUL20) with a total of 1 x 10(10) colony-forming units were administered daily to women during the last month of pregnancy and to infants aged 0-6 mo. Adverse events (AE) were classified according to WHO International Statistical Classification of Diseases criteria. Common symptoms were recorded by regular questionnaires. Baseline characteristics of 220 mother-infant dyads in the treatment and 234 in the placebo group were similar. Compliance with the trial interventions, loss to follow-up, symptoms, drug usage, infant growth, method of feeding, visits to the doctor, and mothers' assessment of infant health were similar in the 2 groups. Fifteen (6.8%) mothers and 73 (33.2%) infants in the treatment group and 21 (9.0%) mothers and 75 (32.1%) infants in the placebo group reported AE (P = 0.49 and P = 0.84, respectively). Severe AE occurred in 18 mothers and 63 infants with a similar frequency in each group. None of the AE were attributed to the intervention. Our findings support the safe use of this consortium of organisms during pregnancy and early infancy.

Integrity signals

Registry

Crossref · 10.3945/jn.109.117093

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In vulnerable patient groups, intestinal barrier dysfunction increases the risk of adverse effects from probiotics.

    “In such vulnerable patient groups, intestinal barrier dysfunction increases the risk of adverse effects from probiotics [81] and may contribute to infection development, which can subsequently lead to sepsis or inflammation [19].”

    From Current Concepts in Probiotic Safety and Efficacy (2026) · cites this paper as [81]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Allen, S. J., Jordan, S., Storey, M., Thornton, C. A., Gravenor, M., Garaiova, I., Plummer, S. F., Wang, D., & Morgan, G.
Affiliations
  • Swansea University (GB)
  • London School of Hygiene & Tropical Medicine (GB)
Corresponding author
Allen, Stephen J.
Venue
The Journal of Nutrition
Publisher
Elsevier BV
Published
2010-03
Volume
140
Issue
3
Pages
483-488
ISSN
0022-3166 (ISSN-L)
OpenAlex
W2014544748
Cited by
119
References
16
Citations by year
2026: 4 · 2025: 8 · 2024: 12 · 2023: 3 · 2022: 7 · 2021: 12 · 2020: 12 · 2019: 7 · 2018: 9 · 2017: 8 · 2016: 6 · 2015: 8 · 2014: 4 · 2013: 8 · 2012: 5
FWCI
9.31
Type
journal article
Language
en
Open access
Locations
  • Journal of Nutrition (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
  • Health Sciences › Health Professions › Pharmacy › Infant Health and Development
Keywords
probiotics, lactobacilli, Bifidobacterium, dietary supplementation, safety, adverse events, atopy prevention, pregnancy, infancy, Lactobacillus salivarius, Lactobacillus paracasei, Bifidobacterium animalis subsp. lactis, Bifidobacterium bifidum, mother-infant dyads
MeSH terms
Adult, Bifidobacterium, Double-Blind Method, Female, Humans, Hypersensitivity, Immediate, Infant, Infant, Newborn, Lactobacillus, Pregnancy, Pregnancy Trimester, Third, Dietary Supplements, Probiotics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review